Cartesian Therapeutics News and Activities

Cartesian Therapeutics is a company listed under the stock ticker SELB (US).

View the org chart displaying its 27 main executives

Most searched biographies at Cartesian Therapeutics

• Carsten Brunn, Chief Executive Officer and Chairman of the Board
• Timothy Springer, Director
• Michael Singer, Director

Popular executive movements at Cartesian Therapeutics

• Miloš Miljković, Chief Medical Officer, will leave the company on May 31, 2026  (posted on May 27 2026).
• Rob Dallimore has joined the company as Vice President of Quality  (posted on April 28 2026).
• Adrian Bot has joined the company as Director  (posted on December 19 2025).

Click here to view some more movements at Cartesian Therapeutics

Create your alert
to follow the executive moves at Cartesian Therapeutics.

Cartesian Therapeutics has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).
• NewLimit has just announced a $435 Million fundraising (posted on June 3 2026).
• Rallybio and Avenzo Therapeutics have announced they will merge  (posted on June 1 2026)..

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Valerie Hanote - Non-Executive Director at Eurofins

Learn more about the Biotechnology industry

Press releases by Cartesian Therapeutics

• Selecta Biosciences Announces Merger with Cartesian Therapeutics | Selecta Biosciences Inc
• News & Events
• Events
• News
• In The News
• Selecta Biosciences to Participate in Upcoming Investor Conferences | Selecta Biosciences Inc
• Selecta Biosciences to Host Conference Call and Webcast to Discuss Second Quarter 2022 Financial Results and Provide Business Update | Selecta Biosciences Inc
• Selecta Biosciences to Participate at the Guggenheim I&I Spotlight Series – Treg-based Therapies Conference | Selecta Biosciences Inc
• Selecta Biosciences Announces Partnership Advancements and Clinical Trial Updates | Selecta Biosciences Inc
• Press Releases | Selecta Biosciences Inc
• View more press releases Close

Social media about Cartesian Therapeutics

• Cartesian Therapeutics on Wikipedia, Google News & Yahoo Finance
• Cartesian Therapeutics on LinkedIn, X (Twitter) & YouTube